Where does A2 Biotherapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), A2 Biotherapeutics, Inc. ranks #23,752 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does A2 Biotherapeutics, Inc. hold?

A2 Biotherapeutics, Inc. holds 11 US utility patents granted between 2022 and 2025, spanning 5 technology areas.

What is A2 Biotherapeutics, Inc.'s Innovation Score?

A2 Biotherapeutics, Inc. has an Innovation Score of 49.9 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does A2 Biotherapeutics, Inc. focus on?

A2 Biotherapeutics, Inc.'s top technology area is C07K (PEPTIDES) with 11 patents. Grants appear in 5 CPC subclasses total.

Is A2 Biotherapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for A2 Biotherapeutics, Inc..

What does claim depth mean for A2 Biotherapeutics, Inc.'s patents?

A2 Biotherapeutics, Inc.'s patents average 22.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the A2 Biotherapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

A2 Biotherapeutics, Inc.

USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (PEPTIDES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, A2 ranks #23,752 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 5 technology areas.

#23,752
of 50,000 US assignees by volume: Top 14%
by Innovation Score (49.9/100): 22.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R23752 · US Corporation #23,752 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #23,752/50,000
PHOTO-FINISH AAC Optics (Nanning)
CPC-NARROW C07K · 5 areas
INNOV-PAR 49.9/100
CLAIMS-DENSE 22.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: AAC Optics (nanning) Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
A2 Biotherapeutics · this assignee

50
3D Lighting Innovati… · lowest

7

What this shows A2's Innovation Score is 49.9/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where A2's grants concentrate

A2 Biotherapeutics, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C07K (PEPTIDES). Peak complete grant year is 2023 (3 grants) versus a trough of 2 in 2022. By volume, A2 sits between A.c. Dispensing Equipment Inc. and Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam.

A2's three-year grant acceleration

A2 Biotherapeutics, Inc. shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

A C Dispensing Eq…

11
A C M I —Societa'…

11
A V Topchiev Inst…

11
A Y Laboratories

11
AAC Optics (Nanni…

11
Abbott Japan

11
Abrado

11
Academisch Medisc…

11
A2 Biotherapeutics ◀

11

What this shows A2 holds 11 patents at rank #23,756, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near A2

By rank, the assignees closest to #23,756 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in A2's primary technology class.

A2's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

A2 Biotherapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	2	18.2%
2023	3	27.3%
2024	3	27.3%
2025partial year	3	27.3%

Which technologies does A2 Biotherapeutics, Inc. patent most?

C07K - PEPTIDES 11

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 11

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 10

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 7

C12Y - ENZYMES 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#23,752

of 50,000 tracked assignees

Innovation Score

49.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.